Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 229 (6%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3283 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-05-19 2023-06-02 192788
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-06-29 2023-11-06 196949
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-07-21 2023-11-06 199515
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213553
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213576
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-22 2024-01-05 214223
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-04-12 2024-05-24 225008
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-07-18 2024-09-20 233349
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-01-16 2025-02-14 247901
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-04-10 2025-04-25 254847
APO-OLMESARTAN 40MG TABLET Resolved 2017-07-31 2018-01-20 17614
APO-OLMESARTAN 20MG TABLET Resolved 2017-08-14 2018-01-19 19231
APO-OLMESARTAN 40MG TABLET Resolved 2018-07-11 2020-09-01 55287
APO-OLMESARTAN 20MG TABLET Avoided shortage 2018-07-15 2018-08-21 55801
APO-OLMESARTAN 20MG TABLET Resolved 2018-12-27 2020-08-10 70529
APO-OLMESARTAN 20MG TABLET Resolved 2022-01-07 2022-02-07 152324
APO-OLMESARTAN 20MG TABLET Actual shortage 2024-01-19 2024-05-10 216711
APO-OLMESARTAN 40MG TABLET Actual shortage 2024-01-19 2024-11-14 216714
APO-OLMESARTAN/HCTZ 25MG 40MG TABLET Resolved 2017-07-25 2017-11-17 16895
APO-OLMESARTAN/HCTZ 12.5MG 20MG TABLET Resolved 2017-07-25 2018-04-23 16900

Showing 2261 to 2280 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 12.5MG TABLET To be discontinued 2024-01-26 2024-08-06 217493
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-CARVEDILOL 25MG TABLET Discontinued 2024-01-26 2024-01-27 217504
APO-CEFPROZIL 500MG TABLET Discontinued 2018-04-04 2018-10-05 44945
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CEPHALEX 250MG TABLET Discontinued 2018-09-07 2019-02-21 60370
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-CICLESONIDE 50MCG SPRAY, METERED DOSE Discontinued 2018-12-20 2018-12-21 70250
APO-CILAZAPRIL 1MG TABLET To be discontinued 2018-09-07 2018-12-28 60373
APO-CIPROFLOX 250MG TABLET Discontinued 2018-09-07 2018-09-15 60379
APO-CIPROFLOX 500MG TABLET Discontinued 2018-09-07 2018-09-15 60382
APO-CIPROFLOX 500MG TABLET Discontinued 2018-09-07 2018-09-15 60385
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388

Showing 101 to 120 of 366